Structural basis for strand-transfer inhibitor binding to HIV intasomes.
Dario Oliveira PassosMin LiIlona K JóźwikXue Zhi ZhaoDiogo Santos-MartinsRenbin YangSteven J SmithYoungmin JeonStefano ForliStephen H HughesTerrence R BurkeRobert CraigieDmitry LyumkisPublished in: Science (New York, N.Y.) (2020)
The HIV intasome is a large nucleoprotein assembly that mediates the integration of a DNA copy of the viral genome into host chromatin. Intasomes are targeted by the latest generation of antiretroviral drugs, integrase strand-transfer inhibitors (INSTIs). Challenges associated with lentiviral intasome biochemistry have hindered high-resolution structural studies of how INSTIs bind to their native drug target. Here, we present high-resolution cryo-electron microscopy structures of HIV intasomes bound to the latest generation of INSTIs. These structures highlight how small changes in the integrase active site can have notable implications for drug binding and design and provide mechanistic insights into why a leading INSTI retains efficacy against a broad spectrum of drug-resistant variants. The data have implications for expanding effective treatments available for HIV-infected individuals.
Keyphrases
- hiv infected
- high resolution
- antiretroviral therapy
- drug resistant
- hiv positive
- human immunodeficiency virus
- electron microscopy
- hiv aids
- hiv infected patients
- hiv testing
- structural basis
- multidrug resistant
- men who have sex with men
- acinetobacter baumannii
- hepatitis c virus
- mass spectrometry
- dna damage
- gene expression
- high speed
- genome wide
- cancer therapy
- sars cov
- transcription factor
- cystic fibrosis
- tandem mass spectrometry
- south africa
- emergency department
- deep learning
- copy number
- drug delivery
- big data
- adverse drug
- electronic health record
- dna binding
- artificial intelligence